A Buzdar

Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.

A Howell, A. Howell, A. Buzdar, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Positron emission tomography using [18F]fluorotamoxifen to evaluate therapeutic responses in patients with breast cancer: preliminary study.

A. Buzdar, D. Podoloff, E. Kim, 1996, Cancer biotherapy & radiopharmaceuticals.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

M Baum, J Cuzick, J F Forbes, 2005, The Lancet.